SCHEMBL6798182

SCHEMBL6798182

NC(=O)c1ccccc1NC(=O)CCCn1cnc(-c2ccccc2)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
HTR1A P08908 3/20 0.45
HTR7 P34969 3/20 0.45
PDCD1 Q15116 1/20 0.43
CD274 Q9NZQ7 1/20 0.43
TP53 P04637 1/20 0.43
HDAC3 O15379 4/20 0.43
HDAC1 Q13547 3/20 0.43
HDAC4 P56524 2/20 0.43
HDAC7 Q8WUI4 2/20 0.43
HDAC2 Q92769 2/20 0.43
HDAC10 Q969S8 2/20 0.43
HDAC11 Q96DB2 2/20 0.43
HDAC8 Q9BY41 2/20 0.43
HDAC6 Q9UBN7 2/20 0.43
HDAC9 Q9UKV0 2/20 0.43
HDAC5 Q9UQL6 2/20 0.43
KDM4E B2RXH2 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15453838 0.76 NR4A2 (0.43) HDAC3HDAC1HDAC4HDAC7HDAC2
SCHEMBL2182496 0.75 PDE10A (0.47) KDM4ECYP2C9
SCHEMBL14554641 0.73 TP53 (0.49) ALDH1A1PDCD1CD274TP53KDM4E
SCHEMBL945461 0.72 ALDH1A1 (0.57) ALDH1A1MEN1KMT2AHTR1AHTR7
SCHEMBL6800486 0.72 ALDH1A1 (0.57) ALDH1A1MEN1KMT2APDCD1CD274
SCHEMBL4419291 0.72 PDE10A (0.49) ALDH1A1CYP2C9
SCHEMBL2841698 0.72 KDM4E (0.45) ALDH1A1TP53KDM4ELMNACYP2C9
SCHEMBL5924494 0.71 PDE10A (0.47) LMNACYP2C9MAPT
SCHEMBL6373482 0.70 SIGMAR1 (0.53) ALDH1A1KMT2AHTR1AHTR7KDM4E
SCHEMBL8097386 0.70 PDE10A (0.43) HDAC3HDAC1HDAC4HDAC7HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040077667-A1 Quinazolinone derivatives FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-04-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040077667-A1 Quinazolinone derivatives PARP1, PARP9, PARP2 ALDH1A1 201/4885MEN1 2385/4885KMT2A 1243/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.